Filament Health Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FLHLF research report →
About the company
Filament Health Corp. is a pioneering company dedicated to the discovery and extraction of natural psychedelic compounds. Its operations encompass the cultivation of psychedelic plants, genetic research, advanced extraction methodologies, and the conduct of internal clinical trials.
- CEO
- Benjamin Lightburn
- IPO
- 2021
- Employees
- 13
- HQ
- Burnaby, BC, CA
Price Chart
- Market Cap
- $26.18K
- P/E
- -0.75
- P/S
- 8.75
- P/B
- 2.45
- EV/EBITDA
- -1.17
- Div Yield
- 0.00%
- Gross Margin
- 87.94%
- Op Margin
- -501.79%
- Net Margin
- -771.42%
- ROE
- -274.09%
- ROIC
- -142.56%
- Revenue
- $616.68K · -71.06%
- Net Income
- $-4,970,272 · 6.61%
- EPS
- $-0.02 · 26.41%
- Op Income
- $-3,669,276
- FCF YoY
- 44.89%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 0.72
- Avg Volume
- 178
Get TickerSpark's AI analysis on FLHLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FLHLF coverage
Recent articles, reports, and earnings notes.
No research on FLHLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FLHLF report →Similar companies
Peers in the same neighborhood.